Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax Inc (NQ: NVAX )

14.34 -0.62 (-4.14%)
Streaming Delayed Price Updated: 12:09 PM EDT, Jul 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax Inc

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
58 59 Next >
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Novavax Stock Is Crashing Today
The vaccine maker gave a warning that no investor wants to hear. 
Via The Motley Fool
Novavax Stock Down On Concern Over Whether The Company Can Continue
Novavax warns that it may not be able to continue as a company. 
Via Talk Markets
Here's The Good News For Novavax Ahead Of Its Fourth-Quarter Report
Novavax is expected to report strong sales growth. But 2023 guidance will be key. 
Via Investor's Business Daily
Earnings Preview: Novavax
Via Benzinga
NVAX Stock Alert: Is Novavax Going Bankrupt?
NVAX stock is tanking after the pharma company said it might not be able to continue operations as sales of its Covid-19 vaccine are weak. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
Via Benzinga
Why Is Sarepta Therapeutics (SRPT) Stock Up 21% Today?
Sarepta Therapeutics (SRPT) stock is heading higher on Wednesday following the release of its latest earnings report and an upgrade. 
Via InvestorPlace
Why Novavax Stock Wilted on Wednesday
It doesn't seem like investors are looking forward to the company's fourth-quarter and full-year 2022 earnings release. 
Via The Motley Fool
More Likely to 5x First: Novavax vs. Ocugen
They skyrocketed before. It could happen again. 
Via The Motley Fool
Why Is Helbiz (HLBZ) Stock Up 37% Today?
Helbiz (HLBZ) stock is on the move Wednesday despite a lack of hard news concerning the electric bike and scooter company. 
Via InvestorPlace
XPEV Stock Alert: What to Know as Xpeng Reports February Vehicle Deliveries
Xpeng (XPEV) stock is worth checking on Wednesday after the electric vehicle (EV) company released delivery data for February. 
Via InvestorPlace
Why Is Novavax (NVAX) Stock Down 26% Today?
Novavax (NVAX) stock is dropping on Wednesday after the vaccine company warned investors about the state of its business. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to start the day with another breakdown of the biggest pre-market stock movers traders need to know about on Wednesday! 
Via InvestorPlace
Resilient Stocks Look To Break Free As Nasdaq, S&P 500 Futures Climb: Brace For More Volatility, Sideways Movement Near Term, Says Analyst
Stocks could attempt to return to their winning ways on Wednesday following the lackluster performance in the previous session. Mixed earnings news flow could, however, act as a dampener. Cues From... 
Via Benzinga
Novavax, AMC Entertainment And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Tesla, Apple, AMC, Novavax, Rivian: Why These 5 Stocks Are Drawing Investors' Attention Today
Via Benzinga
Rivian's Slamming on the Brakes, but This Vaccine Stock Is Falling Harder
A couple of high-profile companies posted big declines in after-hours trading on Tuesday. 
Via The Motley Fool
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
After-Hours Alert: Why Novavax Stock Is Plunging
Novavax Inc (NASDAQ: NVAX) shares are tanking in Tuesday's after-hours session after the company reported weak fourth-quarter re 
Via Benzinga
2 Stocks to Sell or Remove From Your Watchlist in 2023
Both stocks soared during the coronavirus vaccine race, but their time has passed. 
Via The Motley Fool
Coronavirus Vaccine Market To Surpass $95 Billion By 2028
EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NASDAQ:NVAX),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END 
Via FinancialNewsMedia
Exposures COVID-19
Nasdaq, S&P 500 Futures Flatline Ahead Of Housing, Consumer Data: Analyst Pins Hopes On Dollar, Fed Rates To Keep Flickering Rally Hopes Alive
Trading in the U.S. index futures suggests stocks may start Tuesday’s session slightly higher, although the mood could be cautious ahead of some key economic data on the housing market, business... 
Via Benzinga
3 Supercharged Growth Stocks Down 89% to 97% That Billionaires Can't Stop Buying
Beaten-down growth stocks were popular buys during the fourth quarter for some of the brightest billionaire money managers. 
Via The Motley Fool
Earnings Scheduled For February 28, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter. 
Via Benzinga
2 Beaten-Down Stocks That Might Be too Cheap to Ignore
There is an argument for hitting the buy button, but it's important to consider the potential risks too. 
Via The Motley Fool
Harmony Biosciences, The No. 3 Biotech, Just Topped Forecasts; But Concerns Persist
The company offered neither financial guidance nor plans for a new CEO. 
Via Investor's Business Daily
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
58 59 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.